Tuesday, August 3, 2004
United States Patent and Trademark Office
Conference Room in Jefferson Building
500 Dulany Street, Alexandria, VA
Note: New Location at the NEW CARLYLE Campus
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on April27, 2004 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov or contact Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-3900 or email firstname.lastname@example.org to decline or confirm your attendance by July 27, 2004.
9:00 - 9:30 AM
Greetings and Overview
Jasemine C. Chambers Director, TC 1600
9:30 - 10:30 AM
Electronic Issues: Public/Private Pair, et al.
Mary Small, SIRA
10:30 - 10:45 AM
10:45 - 11:30 AM
PCT Unity of Invention:
Julie Burke, Special Programs Examiner TC 1600
11:30 - 1:00 PM
1:00 - 1:45 PM
Examination Issues when claiming Microarrays
Gary Benzion, SPE Art Unit 1637
1:45 - 2:30 PM
Overcoming Prior Art Rejections: Non-enabling art???
Gary Kunz, SPE Art Unit 1616
2:30 - 2:45 PM
2:45 - 3:30 PM
Claim Scope in Gene Therapy Applications
Deborah Reynolds, Practice Specialist TC 1600
3:30 - 4:00 PM
Jasemine C. Chambers, Director, TC 1600